Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > What are your thoughts on the float of shares
View:
Post by DavidRosenberg on Sep 30, 2021 2:12am

What are your thoughts on the float of shares

Do you guys think 40.5m shares outstanding is a lot ? 


After they did a reverse split a while back I think that move was strategic to go onto Nasdaq 

however ever since raza bokhari was ceo since this inception in 2019 the float went from 7.89m shares outstanding to 36m shares outstanding 

that's like 28 million extra shares , Anthony became CEO just recently even if he was on the board , he does not have control as a CEO would have so I think by the time he saw what raza was doing it was to late ?

the lucid deal followed through because dr kotras company was given 4.5m shares outstanding of FSD Pharma's float now we have 40.5 m shares out 

to put into perspective if fsd was 1 billion marketcap stock price would be around $20 USD ?

let's pray to god lucid and pea is worth atleast triple that one day 

I couldn't sleep last night so those are my thoughts for now 

Cheers

Comment by GrahamB on Sep 30, 2021 6:05am
too bad to hear you couldn't sleep. But a little bit of mental math always helps. Here's some back of the envelope sketching to answer your question about whether the number of shares that you have The share number is important as it represents your fractional share ownership of the company But what is more important is  what is that share worth, and what will happen to it ...more  
Comment by Walter333 on Sep 30, 2021 9:27am
Attention class this is Dilution 101with GrahamB, take notes Rosenberg. I wouldn't be able to sleep at night either if I finally came to this realization as well. It's sad how you are constantly a participant in your own dilution seemingly unaware. This is what I was referring to with my comment about this company continually promoting it's balance sheet yet leverages it's risk via ...more  
Comment by JAKPUG4LIFE on Sep 30, 2021 9:31am
Thank you Walter and Graham, exactly correct
Comment by GrahamB on Sep 30, 2021 10:01am
You really get it Walter. There is something that doesnt fit with Davids narrative and his behaviour.
Comment by GrahamB on Sep 30, 2021 10:03am
TBH-I thought you would put a positive spin on this David. Heyt guys, what if I was trying to cut back on beer, or on calories. Wouldnt diluting my beer out from 5% to close to 0% be good then?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities